Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Petr, Szturz"'
Autor:
Viola Salvestrini, Saverio Caini, Melissa Scricciolo, Michael Saerens, Heleen Bollen, Pierluigi Bonomo, Francesca Caparrotti, Luigi Lorini, Marc Oliva, Maria Urbanowicz-Nijaki, Petr Szturz
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionOver the past years, there has been a growing interest in the role of immunotherapy in locally advanced (LA) and recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC). High-quality data from prospective trials are lac
Externí odkaz:
https://doaj.org/article/1638c3f570d04c1db30a1998893980ce
Autor:
Christina E. Henson, Ahmad K. Abou-Foul, Daniel J. Morton, Lachlan McDowell, Sujith Baliga, James Bates, Anna Lee, Pierluigi Bonomo, Petr Szturz, Paul Nankivell, Shao Hui Huang, William M. Lydiatt, Brian O’Sullivan, Hisham Mehanna
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Extranodal extension (ENE) is a pattern of cancer growth from within the lymph node (LN) outward into perinodal tissues, critically defined by disruption and penetration of the tumor through the entire thickness of the LN capsule. The presence of ENE
Externí odkaz:
https://doaj.org/article/64edb13426bc4880b236a1e47a063cc3
Autor:
Alexander R. Siebenhüner, Giorgia Lo Presti, Daniel Helbling, Petr Szturz, Christoforos Astaras, Yannick Buccella, Sara De Dosso
Publikováno v:
Current Oncology, Vol 29, Iss 8, Pp 5604-5615 (2022)
In Switzerland, physicians do not have national guidelines for metastatic colorectal cancer (mCRC) patient care and utilize international versions for management recommendations. Moreover, information about adherence to these guidelines and real-worl
Externí odkaz:
https://doaj.org/article/795046f1213742908bc0f01956c87866
Autor:
Petr Szturz, Jan B. Vermorken
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/5732483582614234b61e72031ded0bde
Autor:
Sara De Dosso, Alexander R. Siebenhüner, Thomas Winder, Alexander Meisel, Ralph Fritsch, Christoforos Astaras, Petr Szturz, Markus Borner
Publikováno v:
healthbook TIMES. Oncology Hematology, Vol 2, Iss 8, Pp 42-49 (2021)
Despite oncological advances over the past years, survival outcomes for patients with pancreatic ductal adenocarcinoma (PDAC) remain poor. For most PDAC patients, the disease is often asymptomatic at early phases and is therefore typically diagnosed
Externí odkaz:
https://doaj.org/article/4833f706e3814a8a9fb69676907e58b8
Autor:
Antonia Stamatiou, Jeremy Jankovic, Petr Szturz, Francois Fasquelle, Rafael Duran, Niklaus Schaefer, Antonella Diciolla, Antonia Digklia
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Arising from the biliary tract, cholangiocarcinoma is a rare and aggressive epithelial cancer. According to the primary site, it can be further classified into intrahepatic, perihilar and distal types. Due to the lack of symptoms early in the disease
Externí odkaz:
https://doaj.org/article/b2c0c81a3076466bb8a84a194747d129
Autor:
Louis Gros, Petr Szturz, Antonella Diciolla, Volker Kirchner, Solange Peters, Niklaus Schaefer, Martin Hubner, Antonia Digklia
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent location. Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. The prognosis is often very
Externí odkaz:
https://doaj.org/article/ee69a0887d2249ad8141abed71019fa8
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Hematogenous dissemination represents a common manifestation of squamous cell carcinoma of the head and neck, and the recommended therapeutic options usually consist of systemically administered drugs with palliative intent. However, mounting evidenc
Externí odkaz:
https://doaj.org/article/2de0536fd7f04cfa84f3e8e3567bde0e
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
The traditional concept of post-treatment surveillance in head and neck cancer patients relies on examinations directed at early detection of disease recurrence and/or second primary tumors. They are usually provided by ear, nose and throat specialis
Externí odkaz:
https://doaj.org/article/505e4332f95f44ada2ed4bed623877df
Autor:
Metcalf, Anagha Gogate, Bryan Bennett, Zia Poonja, Grant Stewart, Ana Medina Colmenero, Petr Szturz, Courtney Carrington, Clara Castro, Eric Gemmen, Ashley Lau, Alberto Carral Maseda, Eric Winquist, Virginia Arrazubi, Desiree Hao, Audrey Cook, Joaquina Martinez Galan, Lisardo Ugidos, David Fernández Garay, David Gutierrez Abad, Robert
Publikováno v:
Cancers; Volume 15; Issue 14; Pages: 3552
This study examined the real-world use of nivolumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). This was a multinational retrospective study (VOLUME) assessing treatment effectiveness and safety out